Drug Pricing Information - Prime Therapeutics
Drug pricing information
All drugs listed on the National Average Drug Acquisition Cost (NADAC) list that are reimbursed at rates either 10% below or 10% above the national average drug acquisition cost.
Georgia NADAC Reports
Jan-Apr — Document #1 | Document #2
(last posted June 15, 2023)
May-Aug — Document #1 | Document #2
(last posted October 15, 2023)
Sep-Dec — Document #1 | Document #2
(last posted February 26, 2024)
(last posted June 15, 2023)
May-Aug — Document #1 | Document #2
(last posted October 15, 2023)
Sep-Dec — Document #1 | Document #2
(last posted February 26, 2024)
Jan-Apr 2021 (last posted Aug. 31, 2021)
May-Aug 2021 (last posted Jan. 14, 2022)
Sep-Dec — Document #1 | Document #2
(last posted Feb. 21, 2022)
May-Aug 2021 (last posted Jan. 14, 2022)
Sep-Dec — Document #1 | Document #2
(last posted Feb. 21, 2022)
Jan-Apr — Document #1 | Document #2
(last posted June 16, 2022)
May-Aug — Document #1 | Document #2
(last posted October 12, 2022)
Sep-Dec — Document #1 | Document #2
(last posted Feb. 17, 2023)
(last posted June 16, 2022)
May-Aug — Document #1 | Document #2
(last posted October 12, 2022)
Sep-Dec — Document #1 | Document #2
(last posted Feb. 17, 2023)
Prime Therapeutics Management versions
West Virginia NADAC Reports
Prime Therapeutics Management versions
Consolidated Appropriations Act Section 204
Login Portals
Compliance / Legal
Company
© 2025 Prime Therapeutics LLC